PAncreatic Disease Cohort of TOuLouse
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- Diagnostic tools
研究概览
简要总结
This study is a prospective cohort dedicated to pancreatic diseases excluding cancer. The aim is to develop positive or differential diagnostic tools between benign potentially malignant or malignant pancreatic pathologies. During this study the investigators collect data and biological samples to support research project.
详细描述
This collection focuses on pathology of the pancreas requiring specific investigations or management for diagnosis or treatment. Pancreatic pathologies can be classified as malignant, potentially malignant or benign tumors. These can be solid or cystic. There is an inflammatory attack on the pancreas, generating acute pancreatitis in the acute period, if the inflammatory manifestations persist, chronic pancreatitis will develop. Some lesions may be at risk of malignancy during their evolution, it is therefore necessary to improve the performance of monitoring and diagnostic tools in order to adapt the management of patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with inflammatory or cystic exocrine pancreatic pathology
- •Patient able to read and understand the information leaflet
- •Patients who have agreed to participate in the study and have signed the free and informed consent
- •Patients affiliated to a social security system (including AME)
排除标准
- •Patient with pancreatic cancer pathology
- •Patients with active cancer, whatever the origin
- •Pregnant or breastfeeding patients
- •Patients under legal protection, guardianship or trusteeship
结局指标
主要结局
Diagnostic tools
时间窗: 3 years after the first inclusion
To develop positive or differential diagnostic tools between benign potentially malignant or malignant pancreatic pathologies
次要结局
- Microbiota(3 years after the first inclusion)
- New targets(3 years after the first inclusion)
- Improvement of management(3 years after the first inclusion)
- Clinical data access(3 years after the first inclusion)